Multiple Sclerosis

View All Conditions

Multiple Sclerosis and Medical Cannabis 

Multiple sclerosis (MS) is a condition of the central nervous system, which includes the brain and spinal cord. MS is an autoimmune disease; the body’s immune system attacks the protective sheath of nerve fibers surrounding the nerve cells. As a result, signals between the brain and the rest of the body are distorted. There are different degrees of nerve damage from MS, causing long and short-term disabilities. 

While there is no cure for MS, there are treatments to ease symptoms and recover from MS attacks. Many patients with MS suffer from chronic muscle stiffness and spasms, and research shows that MS patients who use medical cannabis report significant relief from muscle stiffness. 

Multiple Sclerosis Causes, Symptoms & Treatment

Though there is no known cause for MS, it is considered an autoimmune disease since it involves the body’s immune system attacking its healthy tissues. The risk factors for MS include age, sex, family history, certain infections, race, climate, vitamin D levels, smoking, and certain autoimmune diseases. 

According to the Mayo Clinic, there are several notable complications of MS, including muscle spasms, paralysis, bladder function, mental changes, depression, and epilepsy. Treatment for MS attacks include corticosteroids and plasma exchange. There are also other treatment methods for relapsing-remitting MS that include injectable interferon beta medications or oral solutions. 

Leveraging Cannabinoids for Those Suffering from Multiple Sclerosis 

Researchers in a 2017 study on cannabis use, Parkinson’s disease, and Multiple Sclerosis, published in Complementary Therapies in Medicine, conducted a survey. They reported that in their survey, more than 40% of people with Parkinson’s disease and multiple sclerosis are currently using medical cannabis. The cannabis users with MS in the study also reported “lower levels of neurological dysfunction” and “beneficial effects on mood, memory, and fatigue.” 

Neurologist Dr. John Peter Zajicek and his co-authors conducted the Multiple Sclerosis and Extract of Cannabis (MUSEC) study published in the Journal of Neurology, Neurosurgery & Psychiatry in 2012. The objective of the study was to replicate patient-based findings in previous research. The researchers compared a group of patients with MS taking a placebo with a group of patients with MS taking oral cannabis extract. They then assessed differences in muscle spasticity, walking ability, and physical and psychological impact. The authors findings showed that the patients with multiple sclerosis who took the cannabis extract experienced twice as much relief of muscle stiffness. The cannabis extract also relieved body pain and sleep quality. 

Another study conducted in 2011 and published in the European Journal of Neurology showed that the majority of participants experienced improved spasticity while taking cannabis extract in comparison to a placebo group. 

Medical cannabis also proves to lessen some of the symptoms associated with multiple sclerosis, including a lack of coordination or unsteady gait and blurry vision. Additionally, medical cannabis is known to ease the symptoms of movement disorders like tremors, eases blurred vision for those with glaucoma, and alleviates symptoms of Inflammatory Bowel Disease. Evidence supports that medical cannabis alleviates many of the symptoms associated with MS, giving many hope for a better quality of life. 

View All Conditions

Personalized Cannabis Consultations

Whether you are new to cannabis and need to learn the basics, or are simply trying to achieve more positive cannabis experiences, Veriheal’s coaches are here to help. You have the opportunity to become informed about this wonderful plant. Book an appointment today with one of our compassionate coaches to have a private discussion about your cannabis journey.

Book Consultation

Data Last Updated 10/05/2020

Chat with a

Support Representative Click Here

Phone Support Also Available 24/7

Get Your MMJ Card

Last week we signed up

7,712 patients

for their medical cannabis cards